The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective survey

BACKGROUND: Alemtuzumab (ALZ) is an immune reconstitution therapy for treating relapsing-remitting multiple sclerosis (RRMS). However, ALZ increases the risk of secondary autoimmune diseases (SADs). OBJECTIVE: We explored whether the detection of autoimmune antibodies (auto-Abs) could predict the de...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandgren, Sofia, Novakova, Lenka, Axelsson, Markus, Amirbeagi, Firoozeh, Kockum, Ingrid, Olsson, Tomas, Malmestrom, Clas, Lycke, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061078/
https://www.ncbi.nlm.nih.gov/pubmed/37006489
http://dx.doi.org/10.3389/fneur.2023.1137665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061078/
https://www.ncbi.nlm.nih.gov/pubmed/37006489
http://dx.doi.org/10.3389/fneur.2023.1137665

Ejemplares similares